This target is considered to be critical since the levels of PTP1 expression are consistent with the degree of inhibition of IRS1 tyrosine phosphorylation and GLUT4 translocation that are associated with insulin resistance in the clinical setting. The gene discussed is SLC2A4; the disease is Insulin resistance.